Specialty Pharmacy

Serious vascular events in patients with diabetes can be prevented with aspirin use, according to results of the ASCEND (A Study of Cardiovascular Events iN Diabetes) trial, which were presented at the ongoing ESC Congress in Munich, Germany.

Daily aspirin did not reduce the occurrence of major cardiovascular events a study of more than 12,500 participants considered to be at risk.

Substituting brand name combination drugs for lower-cost generics could have reduced spending by $925 million in 2016.

New drug could serve as a potential treatment option for patients who have shown an inadequate response to conventional disease-modifying drugs.

Genetically humanized mice may help researchers develop treatments for hepatitis D virus.

Top news of the day from across the health care landscape

A recent study discovered a new way to use bioinformatics to determine how a patient’s immune system responds to immunotherapy.

Jesse C. Dresser, JD, Partner, Frier & Levitt, LLC, speaks about pharmacy benefit manager-owned specialty pharmacies and how they can impact independent specialty pharmacies.

This week's featured pharmacist is Lisa Lohr, Pharm D, BCPS, BCOP, a Specialty Medication Therapy Management pharmacist specializing in oncology care.

Improved access to uniform cancer care in rural areas could help reduce disparities seen between rural and urban patients.

Top news of the day from across the health care landscape

Molecular link found between aging and a major genetic cause of 2 neurodegenerative disorders.

Top news of the week from Specialty Pharmacy Times.

A look at last week's top stories in the world of pharmacy.

Lanadelumab (Takhzyro) is the first monoclonal antibody for the treatment of patients 12 years and older with types 1 and 2 hereditary angioedema.

Researchers uncover myelocortical multiple sclerosis, a new subtype of the disease that features neurodegeneration but lacks white matter myelin loss in the brain.

Phase 3 study results showed that the new HIV therapy ibalizumab reduced viral replication and increased immunity in drug-resistant patients.

Top news of the day from across the health care landscape

Machine-learning technique reduces toxic treatment dosing for glioblastoma while maintaining tumor-shrinking benefits.

The FDA approved cenegermin (Oxervate), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea.

Nanoparticles that act as an ‘on and off’ switch could help improve the safety and efficacy of CAR T-cell therapy.

More than 4 in 10 women with asthma may develop chronic obstructive pulmonary disorder, but many risk factors are modifiable.

Top news of the day from across the health care landscape

The latest recommendation from the United States Preventive Services Task Force (USPSTF) states that women aged 30 years or older have a new option.

A recent study finds patients who experience frequent basal cell carcinomas are 3 times more likely to develop other cancers.

Officials with the FDA have approved stiripentol (Diacomit) for the treatment of seizures associated with Dravet syndrome, a rare form of epilepsy.

Pembrolizumab in combination with chemotherapy reduced the risk of death by half in patients with metastatic, non-squamous non-small cell lung cancer compared with chemotherapy alone.

An expert panel of health care providers and patients are recommending that opioid prescribing limits should be based on the operation performed rather than a blanket approach.

Understanding specialty drug pricing, and the flow of health care dollars through the lens of the stakeholders involved.

Interventions must address HIV testing and beliefs among both patients and providers in order to reach underserved populations.